Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis

Exosomes are critical mediators of intercellular communication in the tumor microenvironment. Exosomal circular RNAs (circRNAs) can act as biomarkers and play crucial roles in many cancers, including non-small cell lung cancer (NSCLC). The aim of this study was to explore the functions and regulatory mechanism of exosomal circ_0007385 in NSCLC. The expression levels of circ_0007385, microRNA-1253 (miR-1253), family with sequence similarity 83, member A (FAM83A) mRNA were determined by quantitative real-time PCR (qRT-PCR). Cell Counting Kit-8 (CCK-8), 5-Ethynyl-2′-deoxyuridine (Edu), and colony formation assays were utilized to determine cell proliferation ability. Sphere formation efficiency was determined by sphere formation assay. All protein levels were detected by western blot assay. Exosomes were detected using transmission electron microscopy analysis. Size distribution of exosomes was analyzed by nanoparticle tracking analysis. The interaction between miR-1253 and circ_0007385 or FAM83A was confirmed by dual-luciferase reporter, RNA immunoprecipitation (RIP) and RNA pull-down assays. Mice xenograft model was established to verify the function of circ_0007385 in vivo. Circ_0007385 was upregulated in NSCLC tissues and cells. Knockdown of circ_0007385 inhibited NSCLC cell proliferation and stemness, while exosomal circ_0007385 facilitated NSCLC cell proliferation and stemness. In addition, miR-1253 was a direct target of circ_0007385, and miR-1253 reversed the inhibitory effects of circ_0007385 on cell proliferation and stemness in NSCLC cells. Moreover, FAM83A was a direct target of miR-1253, and miR-1253 suppressed NSCLC cell proliferation and stemness by targeting FAM83A. Furthermore, circ_0007385 knockdown inhibited tumor growth in vivo. Exosomal circ_0007385 promoted NSCLC cell proliferation and stemness by regulating miR-1253/FAM83A axis.

[1]  Mingxiang Cao,et al.  Circ_0004771 Accelerates Cell Carcinogenic Phenotypes via Suppressing miR-1253-Mediated DDAH1 Inhibition in Breast Cancer , 2021, Cancer management and research.

[2]  Cuiping Liu,et al.  miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A , 2020, Cancer management and research.

[3]  Binbin Zhang,et al.  Exosomal Circ-MEMO1 Promotes the Progression and Aerobic Glycolysis of Non-small Cell Lung Cancer Through Targeting MiR-101-3p/KRAS Axis , 2020, Frontiers in Genetics.

[4]  P. Ji,et al.  Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis , 2020, Molecular Cancer.

[5]  Yancheng Ye,et al.  circ_0007385 served as competing endogenous RNA for miR‐519d‐3p to suppress malignant behaviors and cisplatin resistance of non‐small cell lung cancer cells , 2020, Thoracic cancer.

[6]  Tao Yu,et al.  Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation , 2020, Molecular Cancer.

[7]  S. Liang,et al.  CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D Axis , 2020, OncoTargets and therapy.

[8]  S. Batra,et al.  MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3) , 2020, Brain pathology.

[9]  Mai-Qing Yang,et al.  FAM83A Promotes Lung Cancer Progression by Regulating the Wnt and Hippo Signaling Pathways and Indicates Poor Prognosis , 2020, Frontiers in Oncology.

[10]  Q. Su,et al.  Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. , 2020, Genomics.

[11]  Shu Liu,et al.  Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  Yuting Yin,et al.  Emerging roles of circRNA in formation and progression of cancer , 2019, Journal of Cancer.

[13]  Kexin Chen,et al.  FAM83A signaling induces epithelial-mesenchymal transition by the PI3K/AKT/Snail pathway in NSCLC , 2019, Aging.

[14]  Liang Ming,et al.  Exosomal circRNAs: biogenesis, effect and application in human diseases , 2019, Molecular Cancer.

[15]  A. Warth,et al.  FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC , 2019, Cancers.

[16]  Yan-bo Chen,et al.  Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2. , 2019, Gene.

[17]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[18]  Xiang Li,et al.  The Biogenesis, Functions, and Challenges of Circular RNAs. , 2018, Molecular cell.

[19]  Z. Zeng,et al.  Circular RNAs function as ceRNAs to regulate and control human cancer progression , 2018, Molecular Cancer.

[20]  Haimin Li,et al.  The emerging functions and roles of circular RNAs in cancer. , 2018, Cancer letters.

[21]  Yue Zhang,et al.  MicroRNA-1253 suppresses cell proliferation and invasion of non-small-cell lung carcinoma by targeting WNT5A , 2018, Cell Death & Disease.

[22]  Baohua Sun,et al.  Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis , 2018, Journal of Cancer Research and Clinical Oncology.

[23]  Steven G. Gray,et al.  Circular RNAs: Biogenesis, Function and Role in Human Diseases , 2017, Front. Mol. Biosci..

[24]  Shuqing Chen,et al.  FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancer , 2017, Oncogenesis.

[25]  L. Ming,et al.  Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer , 2017, Scandinavian journal of gastroenterology.

[26]  F. Hirsch,et al.  New and emerging targeted treatments in advanced non-small-cell lung cancer , 2016, The Lancet.

[27]  Ming Yao,et al.  MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN , 2015, Oncotarget.

[28]  J. Meldolesi,et al.  Ectosomes and exosomes: shedding the confusion between extracellular vesicles. , 2015, Trends in cell biology.

[29]  Li Yang,et al.  Regulation of circRNA biogenesis , 2015, RNA biology.

[30]  H. A. Rogoff,et al.  Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.

[31]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[32]  H. Asada,et al.  Exosomes in Cancer Microenvironment and Beyond: have we Overlooked these Extracellular Messengers? , 2012, Cancer Microenvironment.

[33]  Ali M. Ardekani,et al.  The Role of MicroRNAs in Human Diseases , 2010, Avicenna journal of medical biotechnology.

[34]  Torsten B. Moeller,et al.  Books Received Pocket Atlas of Sectional Anatomy — Volume I : Head and Neck : 4th Edition Copyright © North American Neuro- O phthalmology Society . Unauthorized reproduction of this article is prohibited . , 2018 .

[35]  L. Bullinger,et al.  Circular RNAs in Cancer. , 2018, Advances in experimental medicine and biology.

[36]  Anchal Vishnoi,et al.  MiRNA Biogenesis and Regulation of Diseases: An Overview. , 2017, Methods in molecular biology.

[37]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[38]  Wei Wu MicroRNA and Cancer , 2011, Methods in Molecular Biology.

[39]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.